Circulation, Vol 51, 414-420, Copyright © 1975 by American Heart Association
PF Cohn, R Gorlin, MV Herman, EH Sonnenblick, HR Horn, LH Cohn and JJ Collins Jr
Postextrasystolic potentiation (PESP) and 1-epinephrine infusion have
previously been shown by the ventriculographic technique to augment left
ventricular wall motion in patients with coronary artery disease. The
present study relates the magnitude of this augmentation to short- term
prognosis in 56 patients with coronary artery disease and a factor already
identified with reduced life expectancy, i.e., an abnormal ejection
fraction (EF less than .50). Forty-two patients received PESP and 14
1-epinephrine infusion. Based on severity of symptoms and technical
suitability, 37 were treated surgically and 19 medically. Mean follwo-up
times were 11.7 and 14.3 months, respectively. The mean increase in EF
induced by PESP or 1-epinephrine infusion was significantly greater in
patients who subsequently had good results from either surgical or medical
therapy than in those who died or had progressive cardiac deterioration. In
addition, those patients with an increase in EF of .10 or greater had a
statistically greater chance of doing well than patients with less
augmentation. Evaluation of change in ejection fraction after inotropic
stimulation in patients with depressed ejection fractions is helpful in
identifying those patients with greatest contractile reserve and hence
better short-term prognosis with eigher medical or surgical therapy.
Because of its ease of performance and greater enhancement of
contractility, PESP is preferred to 1-epinephrine infusion as the inotropic
stimulus of choice.
ARTICLES
Relation between contractile reserve and prognosis in patients with coronary artery disease and a depressed ejection fraction
This article has been cited by other articles:
![]() |
A. N. Mazzadi, X. Andre-Fouet, N. Costes, P. Croisille, D. Revel, and M. F. Janier Mechanisms leading to reversible mechanical dysfunction in severe CAD: alternatives to myocardial stunning Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2570 - H2582. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Wu and J. A.C. Lima Noninvasive Imaging of Myocardial Viability: Current Techniques and Future Developments Circ. Res., December 12, 2003; 93(12): 1146 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Rahimtoola Hibernating Myocardium Has Reduced Blood Flow at Rest That Increases With Low-Dose Dobutamine Circulation, December 15, 1996; 94(12): 3055 - 3061. [Full Text] |
||||
![]() |
D. W. Baker, R. Jones, J. Hodges, B. M. Massie, M. A. Konstam, and E. A. Rose Management of Heart Failure: III. The Role of Revascularization in the Treatment of Patients With Moderate or Severe Left Ventricular Systolic Dysfunction JAMA, November 16, 1994; 272(19): 1528 - 1534. [Abstract] [PDF] |
||||
![]() |
H. S. Friedman Right-Heart Catheterization in Coronary Artery Disease Angiology, December 1, 1978; 29(12): 878 - 887. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1975 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |